90 related articles for article (PubMed ID: 26171921)
1. Expression of Albumin mRNA in Primary Hepatic Neoplasms and Acinar Cell Carcinoma.
Ting DT; Deshpande V
Am J Surg Pathol; 2015 Aug; 39(8):1157-8. PubMed ID: 26171921
[No Abstract] [Full Text] [Related]
2. Letter to the Editor With Regard to the Article Entitled: "Branched Chain In Situ Hybridization for Albumin as a Marker of Hepatocellular Differentiation".
Terris B; Hergli I; Lin-Marq N; Rubbia-Brandt L
Am J Surg Pathol; 2015 Aug; 39(8):1156-7. PubMed ID: 26171920
[No Abstract] [Full Text] [Related]
3. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of albumin gene expression in liver tumors: case report and review of the literature.
Rajkumar SV; Richardson RL; Goellner JR
Mayo Clin Proc; 1998 Jun; 73(6):533-6. PubMed ID: 9621860
[TBL] [Abstract][Full Text] [Related]
5. Detection of albumin messenger RNA in hepatic and extrahepatic neoplasms. A marker of hepatocellular differentiation.
Krishna M; Lloyd RV; Batts KP
Am J Surg Pathol; 1997 Feb; 21(2):147-52. PubMed ID: 9042280
[TBL] [Abstract][Full Text] [Related]
6. Is albumin mRNA detection in the diagnosis of hepatocellular carcinoma better than existing markers?
Yaziji H; Gown AM
Am J Surg Pathol; 2000 Aug; 24(8):1177-9. PubMed ID: 10935665
[No Abstract] [Full Text] [Related]
7. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma.
Hillaire S; Barbu V; Boucher E; Moukhtar M; Poupon R
Gastroenterology; 1994 Jan; 106(1):239-42. PubMed ID: 8276187
[TBL] [Abstract][Full Text] [Related]
8. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
9. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells.
Müller C; Petermann D; Pfeffel F; Oesterreicher C; Függer R
Hepatology; 1997 Apr; 25(4):896-9. PubMed ID: 9096594
[TBL] [Abstract][Full Text] [Related]
10. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
[TBL] [Abstract][Full Text] [Related]
11. [Value of albumin RNAscope in situ hybridization in diagnosis and differential diagnosis of hepatocellular carcinoma].
Chen XY; Dong L; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):400-406. PubMed ID: 35511634
[No Abstract] [Full Text] [Related]
12. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms: A Potential Diagnostic Pitfall.
Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
[TBL] [Abstract][Full Text] [Related]
13. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V
Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
[TBL] [Abstract][Full Text] [Related]
14. In situ hybridisation of albumin mRNA in normal liver and hepatocellular carcinoma with a digoxigenin labelled oligonucleotide probe.
Murray GI; Paterson PJ; Ewen SW; Melvin WT
J Clin Pathol; 1992 Jan; 45(1):21-4. PubMed ID: 1311001
[TBL] [Abstract][Full Text] [Related]
15. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma.
Gion T; Taketomi A; Shimada M; Shirabe K; Hasegawa H; Takenaka K; Sugimachi K
Hepatology; 1998 Dec; 28(6):1663-8. PubMed ID: 9828232
[TBL] [Abstract][Full Text] [Related]
16. Primary liver sarcomatous carcinoma: report of two cases and review of the literature.
Giunchi F; Vasuri F; Baldin P; Rosini F; Corti B; D'Errico-Grigioni A
Pathol Res Pract; 2013 Apr; 209(4):249-54. PubMed ID: 23484778
[TBL] [Abstract][Full Text] [Related]
17. Predictive role BLVRA mRNA expression in hepatocellular cancer.
Kubícková KN; Subhanová I; Konícková R; Matousová L; Urbánek P; Parobková H; Kupec M; Pudil J; Vítek L
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):881-887. PubMed ID: 27740521
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between DNA methylation and expressions of p57kip2 in hepatocellular carcinoma].
Zhao JZ; Zhang ZJ; Shen LJ; Cheng RC; Zhang HX; Qian ZY
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):703-4. PubMed ID: 19785964
[No Abstract] [Full Text] [Related]
19. Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study.
Barbu V; Bonnand AM; Hillaire S; Coste T; Chazouilleres O; Gugenheim J; Boucher E; Poupon R; Poupon RE
Hepatology; 1997 Nov; 26(5):1171-5. PubMed ID: 9362358
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
